Research progress on the application and safety of CD20 monoclonal antibody in children with refractory nephrotic syndrome

Wen Jing, Qin Jianwei, Jiang Weihao, Xu Shitian

PDF(520 KB)
PDF(520 KB)
Adverse Drug Reactions Journal ›› 2025, Vol. 27 ›› Issue (6) : 356-361. DOI: 10.3760/cma.j.cn114015-20241108-00138

Research progress on the application and safety of CD20 monoclonal antibody in children with refractory nephrotic syndrome

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(6): 356-361 https://doi.org/10.3760/cma.j.cn114015-20241108-00138

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(520 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉